Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma.
Authors
Naaz Nasar
Memorial Sloan Kettering Cancer Center, New York, NY
Naaz Nasar , Misha Armstrong , Joanne F. Chou , Mithat Gonen , Kevin Soares , Vinod P. Balachandran , Jeffrey A. Drebin , T. Peter Kingham , Alice Chia-Chi Wei , Michael Ian D'Angelica , Andrea Cercek , James J. Harding , Eileen Mary O'Reilly , Ghassan K. Abou-Alfa , Wungki Park , Louise Catherine Connell , Nancy E. Kemeny , William R. Jarnagin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 522)
DOI
10.1200/JCO.2024.42.3_suppl.522
Abstract #
522
Poster Bd #
E9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
SOGUG-vexillum: Phase II non-randomized clinical trial of nivolumab/ipilimumab maintenance following first-line chemotherapy in unresectable locally advanced or metastatic urothelial cancer.
First Author: Guillermo de Velasco
Poster
2023 ASCO Annual Meeting
Effect of autologous lymphocytes combined with chemotherapy as the first-line treatment of advanced gastric cancer.
First Author: Xiaoting Ma
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical significance of CA125 in unresectable pancreatic cancer treated with first-line chemotherapy.
First Author: Iori Motoo
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN.
First Author: Shun Tezuka